Related Articles
Construction of a novel cell-based assay for the evaluation of anti-EGFR drug efficacy against EGFR mutation
Atypical diffuse bilateral cystic lung changes secondary to erlotinib treatment in a patient with metastatic non‑small cell lung carcinoma: A case report and literature review
Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non‑small cell lung cancer in patients with common and rare EGFR gene mutations
Altered expression of cellular proliferation, apoptosis and the cell cycle-related genes in lung cancer cells with acquired resistance to EGFR tyrosine kinase inhibitors
High efficacy of gefitinib in the treatment of EGFR mutation‑positive advanced non‑small cell lung adenocarcinoma: A case report